GPIHBP1 and multiple sclerosis: One interesting case study also noted a case of acquired GPIHBP1-AAS and hypertriglyceridemia in a patient who was receiving interferon beta-1a for multiple sclerosis; once the interferon therapy was stopped, the triglycerides normalized, suggesting to the authors that the interferon “fueled” a proinflammatory milieu.3